Clinical Trial Update: Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases [Phase 1]

View source ↗

Summary

A Phase I study of intratumoral dendritic cell immunotherapy in thermally ablated liver metastases has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Snippet

Sponsor: Stanford University | Conditions: Liver Cancer | Phase 1 | Status: TERMINATED